← back to search
Morgan A. Sammons
Albany State University · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer-related Molecular Pathways, Genomics and Chromatin Dynamics, Epigenetics and DNA Methylation, and RNA modifications and cancer.
h-index
22
citations
3,799
works
54
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Nature
2018
cited by
854
position: middle
doi
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Science
2016
cited by
1,274
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Sasikanth Manne
· Translational Therapeutics (United States)
1
papers (2016–2016)
Zeyu Chen
· Tongji University
1
papers (2016–2016)
Golnaz Vahedi
· University City Science Center
1
papers (2016–2016)
Caroline Bartman
· California University of Pennsylvania
1
papers (2016–2016)
Makoto Kurachi
· Kanazawa University
1
papers (2016–2016)
Omar Khan
· University of Engineering and Technology Lahore
1
papers (2016–2016)
Shelley L. Berger
· University City Science Center
1
papers (2016–2016)
Kristen E. Pauken
· Brigham and Women's Hospital
1
papers (2016–2016)
Bertram Bengsch
· Deutsche Knochenmarkspenderdatei
1
papers (2016–2016)
W. Nicholas Haining
· Broad Institute
1
papers (2016–2016)
R. Anthony Barnitz
· Dana-Farber Cancer Institute
1
papers (2016–2016)
Pamela M. Odorizzi
· Gilead Sciences (United States)
1
papers (2016–2016)
Debattama R. Sen
· Broad Institute
1
papers (2016–2016)
E. John Wherry
· Translational Therapeutics (United States)
1
papers (2016–2016)
Jernej Godec
· Brigham and Women's Hospital
1
papers (2016–2016)
Adam Drake
· Glenmark Pharmaceuticals (Switzerland)
1
papers (2016–2016)
Jason M. Schenkel
· The University of Texas MD Anderson Cancer Center
1
papers (2016–2016)
Alexander C. Huang
· PolyGene
1
papers (2016–2016)